Affordable Access

deepdyve-link
Publisher Website

Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun.

Authors
  • Siewit, Christina L
  • Gengler, Bridget
  • Vegas, Esera
  • Puckett, Rachel
  • Louie, Maggie C
Type
Published Article
Journal
Molecular Endocrinology
Publisher
The Endocrine Society
Publication Date
May 01, 2010
Volume
24
Issue
5
Pages
981–992
Identifiers
DOI: 10.1210/me.2009-0410
PMID: 20219890
Source
Medline
License
Unknown

Abstract

Cadmium is an environmental contaminant that enters the body through diet or cigarette smoke. It affects multiple cellular processes, including cell proliferation, differentiation, and apoptosis. Recently, cadmium has been shown to function as an endocrine disruptor, to stimulate estrogen receptor alpha (ERalpha) activity and promote uterine and mammary gland growth in mice. Although cadmium exposure has been associated with the development of breast cancer, the mechanism of action of cadmium remains unclear. To address this deficit, we examined the effects of cadmium treatment on breast cancer cells. We found that ERalpha is required for both cadmium-induced cell growth and modulation of gene expression. We also determined that ERalpha translocates to the nucleus in response to cadmium exposure. Additionally, we provide evidence that cadmium potentiates the interaction between ERalpha and c-Jun and enhances recruitment of this transcription factor complex to the proximal promoters of cyclin D1 and c-myc, thus increasing their expression. This study provides a mechanistic link between cadmium exposure and ERalpha and demonstrates that cadmium plays an important role in the promotion of breast cancer.

Report this publication

Statistics

Seen <100 times